Advertisement

Payer

Several Blue Cross Blue Shield companies operated on thinner margins in 2022 than in previous years, as the waning COVID-19 pandemic drove up medical utilization and costs. 

Medicare Advantage and traditional Medicare can differ on clinical quality and costs, but most enrollees are equally satisfied with their coverage, studies published in the last few months have found. 

Advertisement

New drugs such as Ozempic and Wegovy have exploded in popularity for weight loss, but insurers and employers say there is still low interest in covering them because of the high cost.

From organizations pushing back against its new gastroenterology endoscopy prior authorization policy, to its CEO seeing the largest percentage increase in compensation between 2021 and 2022 among large payers, here are 11 updates on UnitedHealth Group Becker's has reported since…

Advertisement